Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Efficacy of Bifeprunox in Patients With Schizophrenia

This study has been terminated.
(Interim analysis showed inadequate efficacy of bifeprunox)
Sponsor:
Information provided by:
H. Lundbeck A/S
ClinicalTrials.gov Identifier:
NCT00704509
First received: June 24, 2008
Last updated: September 24, 2010
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: November 2009
  Primary Completion Date: August 2009 (Final data collection date for primary outcome measure)